Further studies have indicated that PPAR-γ activation has beneficial effects against oxidative stress, mitochondrial dysfunction, and apoptosis in several cell-based models for degenerative diseases such as Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and spinal cord injury [58,59]. This evidence concerns the gene PPARG and neurodegenerative disease.